GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ASEP Medical Holdings Inc (FRA:JJ8) » Definitions » EV-to-Revenue

ASEP Medical Holdings (FRA:JJ8) EV-to-Revenue : 147.70 (As of Jun. 07, 2024)


View and export this data going back to 2022. Start your Free Trial

What is ASEP Medical Holdings EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, ASEP Medical Holdings's enterprise value is €9.45 Mil. ASEP Medical Holdings's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was €0.06 Mil. Therefore, ASEP Medical Holdings's EV-to-Revenue for today is 147.70.

The historical rank and industry rank for ASEP Medical Holdings's EV-to-Revenue or its related term are showing as below:

FRA:JJ8' s EV-to-Revenue Range Over the Past 10 Years
Min: 213.01   Med: 244.46   Max: 260.18
Current: 148.14

During the past 3 years, the highest EV-to-Revenue of ASEP Medical Holdings was 260.18. The lowest was 213.01. And the median was 244.46.

FRA:JJ8's EV-to-Revenue is ranked worse than
86.14% of 1039 companies
in the Biotechnology industry
Industry Median: 7.94 vs FRA:JJ8: 148.14

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-07), ASEP Medical Holdings's stock price is €0.0944. ASEP Medical Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was €0.00. Therefore, ASEP Medical Holdings's PS Ratio for today is 94.40.


ASEP Medical Holdings EV-to-Revenue Historical Data

The historical data trend for ASEP Medical Holdings's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ASEP Medical Holdings EV-to-Revenue Chart

ASEP Medical Holdings Annual Data
Trend Dec21 Dec22 Dec23
EV-to-Revenue
- - 1,195.80

ASEP Medical Holdings Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 1,195.80 235.04

Competitive Comparison of ASEP Medical Holdings's EV-to-Revenue

For the Biotechnology subindustry, ASEP Medical Holdings's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ASEP Medical Holdings's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ASEP Medical Holdings's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where ASEP Medical Holdings's EV-to-Revenue falls into.



ASEP Medical Holdings EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

ASEP Medical Holdings's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=9.453/0.064
=147.70

ASEP Medical Holdings's current Enterprise Value is €9.45 Mil.
ASEP Medical Holdings's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.06 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ASEP Medical Holdings  (FRA:JJ8) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

ASEP Medical Holdings's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.0944/0.001
=94.40

ASEP Medical Holdings's share price for today is €0.0944.
ASEP Medical Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ASEP Medical Holdings EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of ASEP Medical Holdings's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


ASEP Medical Holdings (FRA:JJ8) Business Description

Traded in Other Exchanges
Address
730 View Street, Suite 420, Victoria, BC, CAN, V8W 3Y7
ASEP Medical Holdings Inc is a biotechnology firm pursuing the commercialization of broad-spectrum peptide technology. The Company is dedicated to addressing the global issue of antibiotic failure by developing novel solutions for significant unmet medical needs in human medicine and is engaged in the business of acquiring research and development assets, technology, or businesses in life sciences and medical diagnostics.

ASEP Medical Holdings (FRA:JJ8) Headlines

No Headlines